Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties.
Open accessThe DOI matches its Crossref record.
Abstract
Two 29-kD polypeptides, azurocidin and p29b, were purified to homogeneity from human neutrophils by acid extraction of azurophil granule membrane-associated material followed by gel filtration and reverse-phase chromatography. Azurocidin and p29b share NH2-terminal sequence homology with each other as well as with elastase, cathepsin G, and other serine proteases. p29b bound [3H]diisopropyl fluorophosphate and hydrolyzed elastin, casein, and hemoglobin. A peptide substrate for p29b could not be identified. Azurocidin neither bound [3H]diisopropyl fluorophosphate nor hydrolyzed any of the proteins, peptides, or esters tested. In microbicidal assays, purified azurocidin was comparable to p29b in activity against Escherichia coli, Streptococcus faecalis, and Candida albicans. The antimicrobial activity of azurocidin was enhanced under mildly acidic conditions, but was inhibited in a dose-dependent manner by NaCl, CaCl2, or serum. Immunoblot analysis with monospecific antibodies localized greater than 90% of the azurocidin and greater than 75% of the p29b to azurophil granule-rich fractions of PMN lysates. Immunoelectron microscopy confirmed the localization of azurocidin to the azurophil granules. Azurocidin associated with the azurophil granule membrane, but did not appear to be an integral membrane protein. Thus, azurocidin and p29b are members of a family of serine protease homologs stored in azurophil granules and may play a role in inflammatory and antimicrobial processes involving PMN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Agents that increase the permeability of the outer membrane
Vaara, M. (1992) · Microbiological Reviews · doi:10.1128/mr.56.3.395-411.1992 · Cited by 1,879
Neutrophil Function: From Mechanisms to Disease
Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D., & Zychlinsky, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074942 · Cited by 1,708
Neutrophil granules and secretory vesicles in inflammation
Faurschou, M., & Borregaard, N. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.09.008 · Cited by 1,162
Neutrophils: Molecules, Functions and Pathophysiological Aspects
Witko-Sarsat, V., Rieu, P., Descamps-Latscha, B., Lesavre, P., & Halbwachs-Mecarelli, L. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780067 · Cited by 1,135
Sørensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S., & Borregaard, N. (2001) · Blood · doi:10.1182/blood.v97.12.3951 · Cited by 894
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
Korkmaz, B., Horwitz, M. S., Jenne, D. E., & Gauthier, F. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002733 · Cited by 870
Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment
Yamauchi, K., Tomita, M., Giehl, T. J., & Ellison, R. T. (1993) · Infection and Immunity · doi:10.1128/iai.61.2.719-728.1993 · Cited by 500
Korkmaz, B., Moreau, T., & Gauthier, F. (2008) · Biochimie · doi:10.1016/j.biochi.2007.10.009 · Cited by 480
Kuijpers, T., Tool, A., van der Schoot, C., Ginsel, L., Onderwater, J., Roos, D., & Verhoeven, A. (1991) · Blood · doi:10.1182/blood.v78.4.1105.1105 · Cited by 452
Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential
Kallenberg, C. G. M., Brouwer, E., Weening, J. J., & Cohen Tervaert, J. W. (1994) · Kidney International · doi:10.1038/ki.1994.239 · Cited by 408
Sørensen, O., Arnljots, K., Cowland, J. B., Bainton, D. F., & Borregaard, N. (1997) · Blood · doi:10.1182/blood.v90.7.2796 · Cited by 365
Rao, N. V., Wehner, N. G., Marshall, B. C., Gray, W. R., Gray, B. H., & Hoidal, J. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92854-1 · Cited by 301
Sugawara, S., Uehara, A., Nochi, T., Yamaguchi, T., Ueda, H., Sugiyama, A., Hanzawa, K., Kumagai, K., Okamura, H., & Takada, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6568 · Cited by 297
Human Neutrophil-Mediated Nonoxidative Antifungal Activity against Cryptococcus neoformans
Mambula, S. S., Simons, E. R., Hastey, R., Selsted, M. E., & Levitz, S. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.11.6257-6264.2000 · Cited by 104
Choi, Y.-J., Heo, S.-H., Lee, J.-M., & Cho, J.-Y. (2011) · Proteome Science · doi:10.1186/1477-5956-9-42 · Cited by 71
“Azurocidin was first identified as a cationic antimicrobial protein (CAP) in human polymorphonuclear granulocyte (PMN) granules and exhibits an antimicrobial activity against Gram-negative bacteria (Salmonella typhimurium), Gram-positive bacteria (Staphylococcus aureus) and fungi (Candida albicans) [29,32,33].”
BackgroundGuzman, Y. A., Sakellari, D., Papadimitriou, K., & Floudas, C. A. (2018) · Journal of Periodontal Research · doi:10.1111/jre.12575 · Cited by 29
Azurocidin in gingival crevicular fluid as a potential biomarker of chronic periodontitis
Nalmpantis, D., Gatou, A., Fragkioudakis, I., Margariti, A., Skoura, L., & Sakellari, D. (2020) · Journal of Periodontal Research · doi:10.1111/jre.12703 · Cited by 17
Plant-associated fungi co-opt ancient antimicrobials for host manipulation
Mesny, F., Wolf, V., López-Moral, A., Kraege, A., Punt, W., Liu, S., Zhu, J., Park, J., Sato, Y., & Thomma, B. P. H. J. (2026) · Science Advances · doi:10.1126/sciadv.aec1406 · Cited by 11
Metadata
- Authors
- Campanelli, D., Detmers, P. A., Nathan, C. F., & Gabay, J. E.
- Venue
- Journal of Clinical Investigation
- Published
- 1990-03-01
- Volume
- 85
- Issue
- 3
- Pages
- 904-915
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2163389027
- Cited by
- 218
- References
- 0
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.